Body Composition in Egyptian Turner Syndrome Girls

Overview

Journal Indian J Hum Genet

Specialty Genetics

Date 2013 Sep 11

PMID 24019614

Citations 3

Authors

Moushira Erfan Zaki

Hanan H Afifi

Affiliations

Soon will be listed here.

Abstract

Objective: This cross-sectional study was undertaken to construct the new body fat % curve and provide body composition reference data for adolescent girls with Turner syndrome (TS). They diagnosed cytogenetically by blood karyotyping and not treated with growth hormone (GH).

Materials And Methods: The study included 70 TS girls from age 13 years to age 17 years. Body composition was measured by bioelectrical impedance. Smoothed centile charts were derived by using the least mean square (LMS) method.

Results: The new body fat curves reflect the increase of body fat mass (FM) from age 13 years to age 17 years. Body FM % of Egyptian TS girls was lower when compared with age-matched American untreated TS girls.

Conclusion: This study presents the new body fat curves and reference values of body composition for untreated Egyptian TS adolescent girls. The present charts can be used for direct assessment of body FM % for Egyptian TS girls and evaluation for cases on GH treatment or other growth promoting therapy.

Citing Articles

Carotid Intima-Media Thickness and Cardiometabolic Profile in Turner Syndrome: A Cross-Sectional Study.

Pais-Cunha I, Pereira M, Leite-Almeida A, Pereira Neto B, Ferreira S, Santos Silva R Cureus. 2024; 16(5):e61439.

PMID: 38947673 PMC: 11214767. DOI: 10.7759/cureus.61439.

Clinical and cytogenetic characteristics of patients diagnosed with Turner syndrome in a clinical genetics service: cross-sectional retrospective study.

Nunes M, Pereira T, Correia H, Canabarro S, Vanz A, Gazzola Zen P Sao Paulo Med J. 2021; 139(5):435-442.

PMID: 34378742 PMC: 9632529. DOI: 10.1590/1516-3180.2020.0470.R2.110321.

Nationwide Study of Turner Syndrome in Ukrainian Children: Prevalence, Genetic Variants and Phenotypic Features.

Zelinska N, Shevchenko I, Globa E J Clin Res Pediatr Endocrinol. 2018; 10(3):256-263.

PMID: 29537378 PMC: 6083464. DOI: 10.4274/jcrpe.5119.

References

Holl R, Kunze D, Etzrodt H, TELLER W, Heinze E . Turner syndrome: final height, glucose tolerance, bone density and psychosocial status in 25 adult patients. Eur J Pediatr. 1994; 153(1):11-6. DOI: 10.1007/BF02000780. View

Ari M, Bakalov V, Hill S, Bondy C . The effects of growth hormone treatment on bone mineral density and body composition in girls with turner syndrome. J Clin Endocrinol Metab. 2006; 91(11):4302-5. DOI: 10.1210/jc.2006-1351. View

Hanaki K, Ohzeki T, Ishitani N, Motozumi H, Shiraki K . Fat distribution in overweight patients with Ullrich-Turner syndrome. Am J Med Genet. 1992; 42(4):428-30. DOI: 10.1002/ajmg.1320420405. View

Sas T, de Muinck Keizer-Schrama S, Stijnen T, van Teunenbroek A, van Leeuwen W, Asarfi A . Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study. Pediatr Res. 2001; 50(3):417-22. DOI: 10.1203/00006450-200109000-00019. View

Gravholt C, Juul S, Naeraa R, Hansen J . Prenatal and postnatal prevalence of Turner's syndrome: a registry study. BMJ. 1996; 312(7022):16-21. PMC: 2349728. DOI: 10.1136/bmj.312.7022.16. View

Veldhuis J, Iranmanesh A, Ho K, Waters M, Johnson M, Lizarralde G . Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab. 1991; 72(1):51-9. DOI: 10.1210/jcem-72-1-51. View

Leger J, Carel C, Legrand I, Paulsen A, Hassan M, Czernichow P . Magnetic resonance imaging evaluation of adipose tissue and muscle tissue mass in children with growth hormone (GH) deficiency, Turner's syndrome, and intrauterine growth retardation during the first year of treatment with GH. J Clin Endocrinol Metab. 1994; 78(4):904-9. DOI: 10.1210/jcem.78.4.8157719. View

Gravholt C, Eilersen Hjerrild B, Mosekilde L, Hansen T, Rasmussen L, Frystyk J . Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. Eur J Endocrinol. 2006; 155(4):583-92. DOI: 10.1530/eje.1.02267. View

Ohzeki T, Hanaki K, Motozumi H, Ohtahara H, Urashima H, Shiraki K . Assessment of subcutaneous fat using ultrasonography in the Ullrich-Turner syndrome. Am J Med Genet. 1993; 46(4):450-2. DOI: 10.1002/ajmg.1320460421. View

10.

Gravholt C, Eilersen Hjerrild B, Naeraa R, Engbaek F, Mosekilde L, Christiansen J . Effect of growth hormone and 17beta-oestradiol treatment on metabolism and body composition in girls with Turner syndrome. Clin Endocrinol (Oxf). 2005; 62(5):616-22. DOI: 10.1111/j.1365-2265.2005.02270.x. View

11.

Ohzeki T, Hayashi K, Higurashi M, Hanaki K, Ishitani N, Shiraki K . Ullrich-Turner syndrome and anorexia nervosa. Am J Med Genet. 1989; 32(1):87-9. DOI: 10.1002/ajmg.1320320118. View

12.

Gravholt C, Naeraa R, Brixen K, Kastrup K, Mosekilde L, Jorgensen J . Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study. Pediatrics. 2002; 110(5):889-96. DOI: 10.1542/peds.110.5.889. View

13.

Bengtsson B, Johannsson G . The use of growth hormone in adults: a review of the last 10 years, the present and a perspective for the future. Growth Horm IGF Res. 2000; 8 Suppl B:27-35. DOI: 10.1016/s1096-6374(98)80022-1. View

14.

Williams T, Berelowitz M, Joffe S, Thorner M, Rivier J, Vale W . Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med. 1984; 311(22):1403-7. DOI: 10.1056/NEJM198411293112203. View

15.

Gravholt C, Naeraa R, Fisker S, Christiansen J . Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol. J Clin Endocrinol Metab. 1997; 82(8):2570-7. DOI: 10.1210/jcem.82.8.4127. View

16.

Rasmussen M, Hvidberg A, Juul A, Main K, Gotfredsen A, Skakkebaek N . Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab. 1995; 80(4):1407-15. DOI: 10.1210/jcem.80.4.7536210. View